Intravenous vitamin C as a chemotherapy agent: a report on clinical cases

Riordan, H. D; Riordan, N. H; Jackson, J. A; Casciari, J. J; Hunninghake, R; González, M. J; Mora, E. M; Miranda-Massari, J. R; Rosario, N; Rivera, A

Riordan, H. D; Riordan, N. H; Jackson, J. A; Casciari, J. J; Hunninghake, R; González, M. J; Mora, E. M; Miranda-Massari, J. R; Rosario, N; Rivera, A.

Riordan, H. D; Center for the Improvement of Human Functioning. US
Riordan, N. H; s.af
Jackson, J. A; s.af
Casciari, J. J; s.af
Hunninghake, R; s.af
González, M. J; s.af
Mora, E. M; s.af
Miranda-Massari, J. R; s.af
Rosario, N; s.af
Rivera, A; s.af

P. R. health sci. j ; 23(2): 115-118, Jun. 2004.

Article Dans Anglais | LILACS | ID: lil-390793

RESUMO

RESUMO

A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers. The cancers cases reviewed are the following Renal cell carcinoma (2), Colorectal cancer (1), Pancreatic cancer (1), Non-Hodgkin's lymphoma (2) and breast cancer (1). Toxic reactions were not observed at these high doses of intravenous Vitamin C. All patients were prescreened for Glucose 6--phosphate dehydrogenase deficiency before administering intravenous Vitamin C in order to prevent hemolysis

Sujets)

Recherche sur Google

Imprimer

XML

Indice: LILAS (Amériques) Sujet Principal: Acide ascorbique / Tumeurs / Antinéoplasiques / Antioxydants Limites du sujet: Femelle / Humains / Mâle langue: Anglais Texte intégral: P. R. health sci. j Thème du journal: Médicament Année: 2004 Type: Article Pays d'affiliation: États-Unis d'Amérique Institution/Pays d'affiliation: Center for the Improvement of Human Functioning/US

Documents relatifs à ce sujet

MEDLINE

LILACS

LIS

Recherche sur Google

Imprimer

XML